290 related articles for article (PubMed ID: 24895149)
61. The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer.
Yu G; Wang GX; Wang HG; Mo FF; Tang BB
Neoplasma; 2019 Jul; 66(4):637-640. PubMed ID: 31058531
[TBL] [Abstract][Full Text] [Related]
62. [Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
Reshetnikov OV; Openko TG; Simonova GI; Kurilovich SA; Maliushina SK; Ragino IuI; Voevoda MI
Vopr Onkol; 2012; 58(5):644-8. PubMed ID: 23600281
[TBL] [Abstract][Full Text] [Related]
63. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics.
Lin JT; Wang JT; Wu MS; Huang SC; Wang TH
Hepatogastroenterology; 1993 Dec; 40(6):600-3. PubMed ID: 8119648
[TBL] [Abstract][Full Text] [Related]
64. Histologic and serum risk markers for noncardia early gastric cancer.
Shiotani A; Iishi H; Uedo N; Kumamoto M; Nakae Y; Ishiguro S; Tatsuta M; Graham DY
Int J Cancer; 2005 Jun; 115(3):463-9. PubMed ID: 15688378
[TBL] [Abstract][Full Text] [Related]
65. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period.
Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU
Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404
[TBL] [Abstract][Full Text] [Related]
66. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study.
So JB; Yeoh KG; Moochala S; Chachlani N; Ho J; Wong WK; Mack P; Goh PM
Gastric Cancer; 2002; 5(4):228-32. PubMed ID: 12491081
[TBL] [Abstract][Full Text] [Related]
67. Simultaneous determination of gastric cancer biomarkers pepsinogen PGI/PGII using element tagged immunoassay coupled with inductively coupled plasma mass spectrometry detection.
Jiang W; Sun G; Zhang Y; Hu Z; Wen X; Men S; Xing Z; Zhang S; Huang B; Wang C
J Clin Lab Anal; 2020 Jul; 34(7):e23287. PubMed ID: 32147885
[TBL] [Abstract][Full Text] [Related]
68. High-Negative Anti-
Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
[TBL] [Abstract][Full Text] [Related]
69. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach.
Yu G; Gail MH; Shi J; Klepac-Ceraj V; Paster BJ; Dye BA; Wang GQ; Wei WQ; Fan JH; Qiao YL; Dawsey SM; Freedman ND; Abnet CC
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):735-41. PubMed ID: 24700175
[TBL] [Abstract][Full Text] [Related]
70. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A
Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
[TBL] [Abstract][Full Text] [Related]
71. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
[TBL] [Abstract][Full Text] [Related]
72. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study.
Cai Q; Zhu C; Yuan Y; Feng Q; Feng Y; Hao Y; Li J; Zhang K; Ye G; Ye L; Lv N; Zhang S; Liu C; Li M; Liu Q; Li R; Pan J; Yang X; Zhu X; Li Y; Lao B; Ling A; Chen H; Li X; Xu P; Zhou J; Liu B; Du Z; Du Y; Li Z;
Gut; 2019 Sep; 68(9):1576-1587. PubMed ID: 30926654
[TBL] [Abstract][Full Text] [Related]
73. The non-invasive diagnosis of precancerous changes of stomach mucosa.
Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Polyakova MB; Mernova VP
Rocz Akad Med Bialymst; 2004; 49():66-71. PubMed ID: 15631316
[TBL] [Abstract][Full Text] [Related]
74. Identification of serologically active Helicobacter pylori antigens related to alterations in serum pepsinogen levels.
González Segovia R; Romo Lozano Y; Rodríguez MG; Montañez Flores AL; González Macías J
Rev Argent Microbiol; 2023; 55(4):355-365. PubMed ID: 37385833
[TBL] [Abstract][Full Text] [Related]
75. Helicobacter pylori Infection and Serum Pepsinogen Level With the Risk of Gastric Precancerous Conditions: A Cross-sectional Study of High-risk Gastric Cancer Population in China.
Zhou X; Zhu H; Zhu C; Lin K; Cai Q; Li Z; Du Y
J Clin Gastroenterol; 2021 Oct; 55(9):778-784. PubMed ID: 33116065
[TBL] [Abstract][Full Text] [Related]
76. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
Leja M; Lapina S; Polaka I; Rudzite D; Vilkoite I; Daugule I; Belkovets A; Pimanov S; Makarenko J; Tolmanis I; Lejnieks A; Boka V; Rumba-Rozenfelde I; Vikmanis U
Medicina (Kaunas); 2014; 50(1):8-13. PubMed ID: 25060199
[TBL] [Abstract][Full Text] [Related]
77. Factors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese.
Zhang Z; Sun Lp; Gong YH; Wang XG; Zhang M; Yuan Y
J Dig Dis; 2007 May; 8(2):72-6. PubMed ID: 17532818
[TBL] [Abstract][Full Text] [Related]
78. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen.
Wu KC; Li HT; Qiao TD; Li CN; Ji WS; Tian FQ; Wang X; Wang BL; Miao JY; Ding J; Fan DM
Chin J Dig Dis; 2004; 5(1):22-7. PubMed ID: 15612668
[TBL] [Abstract][Full Text] [Related]
79. Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers.
Shida A; Fukuyama T; Futawatari N; Ohmiya H; Ichiki Y; Yamashita T; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M; Takahashi Y
World J Gastroenterol; 2020 Jan; 26(4):424-432. PubMed ID: 32063691
[TBL] [Abstract][Full Text] [Related]
80. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
Wang X; Zhang Q; Han F; Wu Y
Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]